Is climate risk becoming uninsurable?
Insurers are withdrawing from higher risk regions. And the situation is likely to get worse.
What caught our eye - three key stories
ESG ratings' conflict of interest; Why we aren't cutting fossil fuels; ESO can terminate phantom projects.
Health equity: FDA panel support for sickle cell disease cure
The potential approval of a treatment for a historically under-served community is important.
Risk of taking ESG data as gospel
ESG data is useful as part of the decision-making process. However, it is not THE process.
Sunday Brunch: heart health, dementia and holistic thinking
With sustainability solutions, dropping in substitutes isn't enough. We need to think holistically
Hydrogen for UK home heating ruled out; still important for industry
The 2nd National Infrastructure Assessment report came out during the third week of October. This is particularly interesting: "The Commission’s analysis demonstrates that there is no public policy case for hydrogen to be used to heat individual buildings. It should be ruled out as an option to enable
The beauty of simplification
Sustainable investing evangelist Nawar Alsaadi had a really interesting post on LinkedIn comparing the internet portals of the 1990s to the ESG and sustainability data companies of today. I certainly remember the days of Lycos, Yahoo!, Altavista etc and as Nawar points out they built themselves on being one stop
What caught our eye (week 44)
Risk of taking ESG data as gospel; Health equity - SCD cure?; Is climate risk becoming uninsurable?
CBAM: will carbon border taxes help or harm industries?
The trial period for the EU's Carbon Border Adjustment Mechanism has begun. This could be a game changer, but there is a lot of detail to sort out.
Place-based approaches - economic and social value
Engaging communities in the right way can improve economic resilience, lives and the environment.
Sunday Brunch: horses for courses
The solution (the horse) should match the problem or desired output (the course).
What caught our eye - three key stories
Corporate lobbying as a tool; the beauty of simplification; H2 not for homes, still key for industry